Steven Cohen’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.25M Sell
19,143
-32,043
-63% -$5.2M ﹤0.01% 2091
2026
Q2
$7.88M Buy
+51,186
New +$7.85M 0.01% 1437
2026
Q1
– Sell
-284,437
Closed -$45.5M – 3804
2025
Q4
$45.5M Buy
284,437
+281,337
+9,075% +$33.3M 0.05% 448
2025
Q3
$229K Buy
3,100
+1,800
+138% +$118K ﹤0.01% 2111
2025
Q2
$75K Buy
+1,300
New +$79.3K ﹤0.01% 2088
2024
Q4
– Sell
-4,800
Closed -$225K – 2092
2024
Q3
$225K Sell
4,800
-2,511
-34% -$122K ﹤0.01% 1765
2024
Q2
$334K Sell
7,311
-1,389
-16% -$60.1K ﹤0.01% 1521
2024
Q1
$334K Buy
8,700
+1,000
+13% +$44.8K ﹤0.01% 1753
2023
Q4
$352K Buy
+7,700
New +$296K ﹤0.01% 1664

Other funds holding BLTE

Steven Cohen's BLTE Position: Q3 2026 in Review

Steven Cohen reduced its Belite Bio (BLTE) stake by 63% in Q3 2026, selling an estimated $5.2M and leaving 19,143 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Steven Cohen first reported a position in BLTE in Q4 2023 and has held it in 9 quarters since. The position peaked at $45.5M in Q4 2025. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Steven Cohen held 19,143 shares of Belite Bio worth $3.25M as of Q3 2026.
  • Steven Cohen sold 32,043 Belite Bio shares in Q3 2026, an estimated $5.2M.
  • Belite Bio made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2091 holding.
  • Steven Cohen first reported a position in Belite Bio in Q4 2023 and has held it in 9 quarters since.
  • Steven Cohen's Belite Bio position peaked at $45.5M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.